CIPA Guide to the Patents Acts

Foreword Professor Sir Robin Jacob
Guest Foreword Chief Judge Randall Rader

PATENTS ACT 1977
Arrangement of sections
Amendments to Patents Act 1977
Sections and Schedules with: Relevant Rules; Commentary and Practice, including the following:
Contains an extensively rewritten discussion of patentable subject matter (s. 1) evaluating the impact of the landmark decision of the EPO Enlarged Appeal in G3/08 PRESIDENT S REFERENCE and numerous subsequent decisions of the UK IP Office, UK courts and the EPO Appeal Boards
Updates its discussion of novelty (s.2) explaining landmark Court of Appeal decisions in Gemstar v TV Guide, Leo Pharma v Sandoz and Dr Reddy s v Eli Lilly (selection inventions) and numerous EPO Appeal Board decisions
Contains a re-written review of inventive step (s. 3), explaining decisions of the House of Lords in Conor v Angiotech and Generics v Lundbeck and landmark Court of Appeal decisions including e.g. Schlumberger v Elecgtromagnetic Geosciences, Napp v Ratiopharm, Virgin Atlantic v Premium Aircraft Interiors and Generics v Daiichi; also explaining how the EPO's PSA approach differs as between mere alternatives and advantageous alternatives
Contains a revised discussion on industrial applicability (s. 4) following the House of Lords decision in Eli Lilly v Human Genome Sciences
Updates its explanation of methods of treatment and diagnosis including the key decisions of the EPO Enlarged Appeal Board in G2/08 ABBOTT RESPIRATORY/Dosage Regime and G1/07 MEDI_PHYSICS/Treatment by surgery (s. 4A)
Revises the treatment of biotechnological inventions (76A) updated to include e.g. MedImmune v Novartis
Updates the discussion of Supplementary Protection Certificates (s. 125B), provides the latest version of Regulation (EC) 469/2009 and discusses the latest UK and European decisions on SPCs.
Reviews the latest decisions on insufficiency including CoreValve v Edwards Lifesciences, Ratiopharm v Alza, HTC Corp v Yozmot, Schlumberger v Electromagnetic Geosciences and Novartis v Johnson & Johnson and numerous decisions of the EPO Appeal Board (s. 14)
Explains the latest opinions on infringement (s. 60) including Virgin Atlantic v Delta (kit of parts), Medimmune v Novartis (direct product of patented process), Rambaxy v AstraZeneca (use claims), Grime v Scott (contributory infringement) and Schutz v Werit (license to repair)
Updates extent of protection (125) to include key decisions e.g. in Ancon v ACS Stainless Steel fixings, Dyson v Samsung, Medimmune v Novartis and Virgin Atlantic v Premium Aircraft Interiors.
Outlines key decisions on groundless threats (s.70) under the amended section, including Zeno Corp v BSM-Bionicand FNM Corp v Drammock
Explains the new Patents Court procedures set out in CPR Part 63 and the new Practice Direction together with the new procedure in the Patents County Court (s. 61 and Appendix F).
Reviews new procedures for dispute handling in the UK IP Office (s. 123)


PATENTS RULES 2007
Titles of Rules with cross-references to text locations

COPYRIGHT, PATENTS AND DESIGNS ACT 1988
Arrangement of sections in Parts V and VI
Sections 274 295 with Commentary

APPENDICES
A: History of United Kingdom Patent Law
B: Supplementary Protection Certificates
C: The Biotechnology Directive
D: The Treaty on the Functioning of the European Union (TFEU)
E: Civil Procedure Rules (Extracts)
F: Part 63 of the Civil Procedure Rules
G: Patents Court Guide and Patents County Court Guide
H: Patent Attorney and Trade Mark Attorney Qualification and Registration Regulations 2009
I: Rules for Examination and Admission of Individuals 2011
J: Rules of Conduct for Patent Attorneys, Trade Mark Attorneys and Other Regulated Persons
K: Special Rules of Professional Conduct Applicable to Regulated Persons Conducting Litigation or Exercising a Right of Audience Before the Court